
OUR JOURNEY
Silica Corpora was born as a result of the main purpose of the founders, Timofei and Jaime, to respond to challenges in drug discovery exploiting recent advances in computational technologies.
OUR MISSION
Design, not discovery
The estimated cost of bringing a new prescription drug to the market has risen dramatically from $1.1B in 2003 to $2.3B in 2019 while early stages of drug discovery take around 3 years. The replacement of lead generation and lead optimization stages of antibody drug discovery with AI may reduce the times and costs of early antibody discovery by 10-100 times while improving its quality and accuracy.
"Our mission is to develop tailored AI-solutions to develop more-quality and more cost-effective antibody therapeutics, turning historical data of previous Drug Discovery projects into valuable assets, significantly reducing the prospective sunk costs."

Our Team
Our expertise supports our results
Our Journey So Far
